A former Food and Drug Administration (FDA) official says he’d be "shocked" if the DEA does not reschedule cannabis by next year's presidential election, and that he expects the DEA will ultimately accept the recent Health and Human Services’ recommendation to ease restrictions on cannabis by reclassifying it as a Schedule III drug under the Controlled Substances Act.
“I would be really shocked if it took the DEA longer than the second quarter of next year to come up with its final rule,” said Howard Sklamberg, former …